CONTRAFECT Corp - CFRXQ

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$297K
QoQ value delta ($000)
+$177K (+147.5%)
Implied price effect (QoQ)
-61.26%
Shares
Total shares
525,521
QoQ shares delta
+443,256 (+538.81%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CFRXQ)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 270 475,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 13 23,547 0.0%
VANGUARD GROUP INC 9 16,304 0.0%
Tower Research Capital LLC (TRC) 5 10,182 0.0%
JPMORGAN CHASE & CO 0 62 0.0%
BANK OF AMERICA CORP /DE/ 0 6 0.0%
WELLS FARGO & COMPANY/MN 0 27 0.0%
FMR LLC 0 1 0.0%
MORGAN STANLEY 0 119 0.0%
GROUP ONE TRADING, L.P. 0 1 0.0%
ROYAL BANK OF CANADA 0 271 0.0%
UBS Group AG 0 1 0.0%